Thryve, a Berlin-based B2B health data integration and analytics startup, has raised €4 million in a Series A funding round to advance automated HealthCare.
Capricorn Partners, based in Belgium, led the fundraising round. IBB Ventures, CRB Health Tech, based in Spain, and the German Carma Fund also provided support.
This significant investment will strengthen the company’s international expansion goals and enhance its wearable integration capabilities for automated prevention and treatment.
Health providers throughout the globe are now able to continuously monitor and understand a person’s health state using data gathered from hundreds of health trackers thanks to Thryve’s unified API, which is at the forefront of health data integration. This technology is essential to the provision of automated, preventative care that is available anytime, anyplace.
Over 50 million people in Europe have already accessed Thryve’s early prevention solutions through their health insurance, demonstrating the widespread adoption of its technology. Thryve partners with major players such as Sanitas in Spain and AOK in Germany, integrating its technology directly into their operations. Digital therapeutics uses Thryve’s data integration, such as the industry-leading DiGA-certified Sidekick Rx, to improve proactive care and individualization, especially when treating obesity with its product Zanadio.
Related Content: Healthcare Compliance Platform – Naq Raises €3 Million
The need for Automated HealthCare far outstrips supply as developed countries struggle with an aging population and a declining labor force. The pressure on the HealthCare system will only increase as more than thirty percent of doctors in Germany plan to retire in the next five years. Digital health services are gaining popularity among payers, customers, and regulators because they offer quicker and more proactive care. With one in two people currently using a health tracker and the industry expanding by more than 20% yearly, Thryve’s technology is essential for both preventing sickness through early diagnosis and guaranteeing ongoing access to relevant healthcare insights.
Thryve focuses on enhancing early disease detection and treatment using fully automated, at-home solutions, leveraging health trackers. The recent funding empowers the company to enhance its analytics and preventive health capabilities while expanding its customer base, which now spans over 20 countries. Thryve currently provides tests for mental, cardiovascular, and metabolic health. It also intends to expand its range of markers and enable users to run their algorithms via its engine.
Statements:
Friedrich Lammel, CEO of Thryve, expressed similar zeal, saying:
“HealthCare is undergoing an epochal transition.” In the next five years, our engine, in my opinion, will help the industry add 20 healthy years to people’s lives and render millions of doctor visits unnecessary. We are eager to accelerate our growth in this mission and are thrilled to work with top European health funds.
Capricorn Partners’ Investment Director, Antoine D’Hollander, said:
“This new funding aligns with our strategy to utilize real-world data for personalized prevention and therapeutics. We are thrilled about Thryve’s solution, which integrates data from multiple wearables and health applications to build an affordable HealthCare ecosystem that allows for efficient monitoring and customized interventions.”
